New investigations propose that DSIP represents the viable therapeutic candidate. Preliminary results show its involvement in modulating rest and possibly addressing several neurological and psychiatric ailments. Additional assessment is essential to thoroughly define a mechanism of action and substantiate its clinical benefit in patient samples.